Fresenius Medical Care AG & Co KGaA ADR Stock
Fresenius Medical Care AG & Co KGaA ADR gained 2.090% today.
Our community is currently high on Fresenius Medical Care AG & Co KGaA ADR with 4 Buy predictions and 1 Sell predictions.
With a target price of 21 € there is a slightly positive potential of 7.69% for Fresenius Medical Care AG & Co KGaA ADR compared to the current price of 19.5 €.
Pros and Cons of Fresenius Medical Care AG & Co KGaA ADR in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Fresenius Medical Care AG & Co KGaA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co KGaA ADR | 2.090% | 4.278% | 13.372% | -8.019% | 4.278% | -41.964% | -47.581% |
| Carl Zeiss Meditec AG | 0.150% | -2.291% | -11.622% | -18.250% | -0.588% | -34.513% | 11.859% |
| Fresenius SE & Co. KGaA | -1.030% | 2.378% | 13.740% | 8.576% | -0.956% | -31.922% | -45.901% |
| Fresenius SE & Co. KGaA ADR | 1.480% | 3.008% | 14.167% | 7.874% | -2.143% | -32.178% | -45.200% |
Comments
Fresenius Medical Care AG (NYSE: FMS) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for FMS provided by MarketBeat
Fresenius Medical Care AG (NYSE: FMS) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for FMS provided by MarketBeat
Fresenius Medical Care AG (NYSE: FMS) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating.
Show more
Ratings data for FMS provided by MarketBeat